Phase 2 Study of ISL+ULO QW in Virologically Suppressed Adults With HIV-1 (NCT06891066)
MK-8591B 060
This trial is No longer recruiting
Registration number NCT06891066
Program & service
This trial is being run with the Infectious Diseases service, and as part of the Infectious Diseases program.
Trial phase
Phase 2
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Professor James McMahon
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR